| Author/Editor | Čufer, T; Vrdoljak, E | |
| Title | Results from a phase II, open-label, randomized study (SIGN) comparing gefitinib with docetaxel as second-line theraphy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer | |
| Type | članek | |
| Source | J Clin Oncol | |
| Vol. and No. | Letnik 23, št. 16 | |
| Publication year | 2005 | |
| Volume | str. 629s | |
| Language | eng |